Paper36052124
Progress on structural modification of Tetrandrine with wide range of pharmacological activities.
Mo L and 11 others. Front Pharmacol, 2022. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Progress on structural modification of Tetrandrine with wide range of pharmacological activities. Papers, record 36052124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36052124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Progress on structural modification of Tetrandrine with wide range of pharmacological activities.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References210
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26642721 | Tetrandrine Inhibits the Intracellular Calcium Ion Level and Upregulates the Expression of Brg1 and AHNAK in Hep-2 Cells. | Clin Lab | 2015 | https://conductscience.org/library/papers/26642721 | PubMed |
| 2 | 34165909 | Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization. | Adv Healthc Mater | 2022 | https://conductscience.org/library/papers/34165909 | PubMed |
| 3 | 22001142 | Tetrandrine down-regulates ERK/NF-κB signaling and inhibits activation of mesangial cells. | Toxicol In Vitro | 2011 | https://conductscience.org/library/papers/22001142 | PubMed |
| 4 | 28393256 | Tetrandrine inhibits the proliferation of human osteosarcoma cells by upregulating the PTEN pathway. | Oncol Rep | 2017 | https://conductscience.org/library/papers/28393256 | PubMed |
| 5 | 29731901 | Tetrandrine suppresses adhesion, migration and invasion of human colon cancer SW620 cells via inhibition of nuclear factor-κB, matrix metalloproteinase-2 and matrix metalloproteinase-9 signaling pathways. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29731901 | PubMed |
| 6 | 29700286 | c-MYC and reactive oxygen species play roles in tetrandrine-induced leukemia differentiation. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29700286 | PubMed |
| 7 | 29147842 | Tetrandrine Alleviates Nociception in a Rat Model of Migraine via Suppressing S100B and p-ERK Activation in Satellite Glial Cells of the Trigeminal Ganglia. | J Mol Neurosci | 2018 | https://conductscience.org/library/papers/29147842 | PubMed |
| 8 | 26838734 | Multilayer Coating of Tetrandrine-loaded PLGA nanoparticles: Effect of surface charges on cellular uptake rate and drug release profile. | J Huazhong Univ Sci Technolog Med Sci | 2016 | https://conductscience.org/library/papers/26838734 | PubMed |
| 9 | 24204145 | Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers. | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/24204145 | PubMed |
| 10 | 18851784 | [Inhibitory effect of tetrandrine on angiogenesis]. | Ai Zheng | 2008 | https://conductscience.org/library/papers/18851784 | PubMed |
| 11 | 32349635 | Preparation and characterisation of tetrandrine nanosuspensions and in vitro estimate antitumour activity on A549 lung cancer cell line. | J Microencapsul | 2020 | https://conductscience.org/library/papers/32349635 | PubMed |
| 12 | 21966359 | Reversion of pH-induced physiological drug resistance: a novel function of copolymeric nanoparticles. | PLoS One | 2011 | https://conductscience.org/library/papers/21966359 | PubMed |
| 13 | 34247115 | Tetrandrine ameliorated Alzheimer's disease through suppressing microglial inflammatory activation and neurotoxicity in the 5XFAD mouse. | Phytomedicine | 2021 | https://conductscience.org/library/papers/34247115 | PubMed |
| 14 | 30363745 | Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/30363745 | PubMed |
| 15 | 15673192 | Inhibitory effect of tetrandrine on pulmonary metastases in CT26 colorectal adenocarcinoma-bearing BALB/c mice. | Am J Chin Med | 2004 | https://conductscience.org/library/papers/15673192 | PubMed |
| 16 | 23662696 | Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies. | Drug Dev Ind Pharm | 2014 | https://conductscience.org/library/papers/23662696 | PubMed |
| 17 | 32942071 | Synthesis, biological evaluation and toxicity of novel tetrandrine analogues. | Eur J Med Chem | 2020 | https://conductscience.org/library/papers/32942071 | PubMed |
| 18 | 32765280 | JNK and Autophagy Independently Contributed to Cytotoxicity of Arsenite combined With Tetrandrine via Modulating Cell Cycle Progression in Human Breast Cancer Cells. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32765280 | PubMed |
| 19 | 26213467 | Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system. | Int J Nanomedicine | 2015 | https://conductscience.org/library/papers/26213467 | PubMed |
| 20 | 25862829 | Tetrandrine reverses human cardiac myofibroblast activation and myocardial fibrosis. | Am J Physiol Heart Circ Physiol | 2015 | https://conductscience.org/library/papers/25862829 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883336 | Selective Cytotoxic Activity of Derivatives of the Natural Alkaloid Tetrandrine Against Cancer Cell Lines: In Vitro and In Silico Studies. | Molecules | 2026 | https://conductscience.org/library/papers/42883336 | PubMed |
| 42344889 | Tetrandrine enhances anti-PD-1 immunotherapeutic efficacy for hepatocellular carcinoma by activating STING/TBK1/IRF3 pathway. | Front Immunol | 2026 | https://conductscience.org/library/papers/42344889 | PubMed |
| 42322357 | Emerging role of plant-based compounds as ferroptosis modulators in breast cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42322357 | PubMed |
| 42137439 | Tetrandrine, a Major Alkaloid From Stephaniae Tetrandrae Radix, Ameliorates Non-Alcoholic Fatty Liver Disease in Zebrafish via the PI3K/AKT/STAT3 Pathway. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42137439 | PubMed |
| 40520178 | Targeting the programmed cell death signaling mechanism with natural products for the treatment of acute pancreatitis: a review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40520178 | PubMed |
| 40406100 | A comprehensive review of natural products in rheumatoid arthritis: therapeutic potential and mechanisms. | Front Immunol | 2025 | https://conductscience.org/library/papers/40406100 | PubMed |
| 40016522 | Tetrandrine augments melanoma cell immunogenicity via dual inhibition of autophagic flux and proteasomal activity enhancing MHC-I presentation. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/40016522 | PubMed |
| 39606807 | Insights on exploring the therapeutic potential and structural modification of Tetrandrine. | Future Med Chem | 2024 | https://conductscience.org/library/papers/39606807 | PubMed |
| 39548359 | Tetrandrine induces muscle atrophy involving ROS-mediated inhibition of Akt and FoxO3. | Mol Med | 2024 | https://conductscience.org/library/papers/39548359 | PubMed |
| 38568399 | Therapeutic effects of tetrandrine in inflammatory diseases: a comprehensive review. | Inflammopharmacology | 2024 | https://conductscience.org/library/papers/38568399 | PubMed |
| 38445699 | Tetrandrine for Targeting Therapy Resistance in Cancer. | Curr Top Med Chem | 2024 | https://conductscience.org/library/papers/38445699 | PubMed |
| 38265677 | Tetrandrine Alleviates Silica-induced Pulmonary Fibrosis Through PI3K/AKT Pathway: Network Pharmacology Investigation and Experimental Validation. | Inflammation | 2024 | https://conductscience.org/library/papers/38265677 | PubMed |
| 38140764 | Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38140764 | PubMed |
| 37653727 | Identification of propranolol and derivatives that are chemical inhibitors of phosphatidate phosphatase as potential broad-spectrum fungicides. | Plant Commun | 2024 | https://conductscience.org/library/papers/37653727 | PubMed |
| 36771152 | Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer's Disease. | Molecules | 2023 | https://conductscience.org/library/papers/36771152 | PubMed |
Genes85
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36052124
GET https://conductscience.org/api/papers/v1/36052124/references?page=2